Tilray, Inc. (NASDAQ:TLRY), a worldwide pioneer in cannabis analysis, cultivation, production and distribution, right now announced it has entered into an agreement with Cannamedical Pharma GmbH (“Cannamedical”) via its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”), to export a wholesale shipment of $three.three (€3) million worth of health-related cannabis from Portugal to Germany. The shipment, which is anticipated to be completed in fall 2019, will be Tilray’s initial from its state-of-the-art EU campus in Portugal to provide individuals in Germany.
“This is a important milestone for Tilray as we ramp up our capacity to serve international markets and produce income from our EU campus via the finish of 2019,” says Tilray CEO Brendan Kennedy. “We think our two.five million square feet of cultivation and state-of-the-art processing space in Europe is an vital differentiator, which will allow us to cut down charges and boost margins when hedging against regulatory threat.”
– Study the whole write-up at Monetary Post.